Company: TDBCP
Filing Date: 2025-04-03
Form Type: 424B3
Source: 0001140361-25-012065
Chunk: 6

Company: TORONTO DOMINION BANK
Filing Date: 2025-04-03
Form: 424B3
Chunk 6
---
 reason, including when taking any corporate actions that might adversely affect the price of an Underlying Stock or the value of ARNs. No Underlying Company will receive any of the proceeds from any offering of ARNs, or be responsible for, or participate in, the offering of ARNs, and no Underlying Company will be responsible for, or participate in, the determination or calculation of the amount payable on ARNs. None of us, the agents or any of our or their respective affiliates will conduct any due diligence inquiry with respect to any Underlying Stock in connection with an offering of ARNs. None of us, the agents or any of our or their respective affiliates has made any independent investigation as to the completeness or accuracy of publicly available information regarding any Underlying Stock or Underlying Company or as to the future performance of the Underlying Stock. Any purchaser of ARNs should undertake such independent investigation of an Underlying Stock and an Underlying Company as in its judgment is appropriate to make an informed decision with respect to an investment in ARNs. The payment on ARNs will not be adjusted for all corporate events that could affect an Underlying Company.The Price Multiplier or other terms of ARNs may be adjusted for the specified corporate events affecting any Underlying Stock, as described under “Description of ARNs—Anti-Dilution Adjustments.” However, these adjustments do not cover all corporate events that could affect the market price of an Underlying Stock, such as offerings of common shares for cash or in connection with certain acquisition transactions. The occurrence of any event that does not require the calculation agent to adjust the Price Multiplier, the amount paid to you at maturity or any other terms of ARNs may adversely affect the Closing Market Price of that Underlying Stock, the Ending Value and, as a result, any payment on, and the market value of, ARNs. Risks Relating to Underlying Stocks That Are ADRs The value of an ADR may not accurately track the value of the common shares of the related Underlying Company.If an Underlying Stock is an ADR, each ADR will represent shares of the relevant Underlying Company. Generally, the ADRs are issued under a deposit agreement that sets forth the rights and responsibilities of the depositary, the Underlying Company and the holders of the ADRs. The trading patterns of the ADRs will generally reflect the characteristics and valuations of the underlying common shares; however, the value of the ADRs may not completely track the value of those shares.